NCT00828763View on ClinicalTrials.gov

GSK1349572 Mass Balance Study

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Healthy Volunteer

Interventions

DRUG

[14c}-GSK1349572

HIV-Integrase inhibitor labelled with a carbon 14 marker

Trial Locations (1)

53704

GSK Investigational Site, Madison

Sponsors

Lead Sponsor

GlaxoSmithKline

Collaborators (1)

All Listed Sponsors

collaborator

Shionogi

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY